Quang DoanPhD

Quang Doan combines deep scientific expertise with extensive experience advising innovative businesses across the biotechnology, pharmaceutical and MedTech sectors. With a PhD in Chemical Engineering and a career spanning drug development, bioprocess engineering, GMP manufacturing and biotechnology R&D, he brings first-hand experience of the scientific challenges that underpin innovation.

The most important advances in healthcare begin long before anyone sees the outcome. Progress depends on creating the conditions for scientists to keep pursuing the unknown.

Having worked as a scientist, researcher and technical leader, Quang understands that meaningful innovation emerges from uncertainty. His practical experience in highly regulated life sciences environments enables him to engage directly with researchers, technical teams and company executives, helping them articulate complex scientific activities within the framework of Australia's R&D legislation.

At RDI Partners, Quang specialises in working with biotechnology, pharmaceutical and MedTech companies to ensure their innovation activities are accurately represented, scientifically substantiated and strategically aligned with legislative requirements. He is particularly valued for his ability to bridge the gap between complex science and compliance obligations, ensuring innovative businesses can focus on advancing technologies that improve lives.

Expertise

• Biotechnology and pharmaceutical innovation.
• Scientific uncertainty and experimental design.
• Life sciences regulatory and legislative interpretation.